The novel estrogen receptor modulator STX attenuates Amyloid-β neurotoxicity in the 5XFAD mouse model of Alzheimer's disease
Joseph F. Quinn(Oregon Health & Science University), Philip F. Copenhaver(Oregon Health & Science University)
Cited by 14
Related Papers
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease
|Alzheimer s & Dementia|2008|410
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
|The Lancet Neurology|2023|128
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical Trial
|Journal of Clinical Medicine|2020|32
Manduca Contactin Regulates Amyloid Precursor Protein-Dependent Neuronal Migration
|Journal of Neuroscience|2016|11